Early study results were so promising that the trial closed early, with findings published in the New England Journal of Medicine ...

Running a clinical trial requires enough patient participants to gather robust data so that researchers can draw appropriate conclusions...

Doctors at Seattle Children's Hospital are the first to use immunotherapy to fight brain cancer. It is the most common and deadliest form...

Why is it so hard to develop drugs for children with cancer? And what can be done about it? Those questions are central to a new study...

In today’s golden age of cancer research, experimental therapies are curing tough-to-treat cancers like never before. But a child’s...

NCI-COG Pediatric Molecular Analysis for Therapy Choice (Pediatric MATCH) is a nationwide trial to explore whether targeted therapies can...

The National Brain Tumor Society (NBTS) announced the launch of a new brain-tumor clinical trial finder to engage patients in new...

A team of officials at the US Food and Drug Administration (FDA) are calling for a "culture shift" by drugmakers, regulators and clinical...

The dramatic improvements in survival for children with cancer depend on these clinical trials, and these trials depend on parents...

Seattle Children’s today announced the opening of patient enrollment for its new cellular immunotherapy clinical research trial designed...